Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Trinity Biotech (TRIBY) -- Ignore unavailable to you. Want to Upgrade?

To: PAR who wrote (7390)	11/17/1997 6:41:00 PM
From: Scott H. Davis	Respond to of 14328

Paula & BB, everybody can create trends out of a few issues. But you may want to consider the fate of ISIP and VICL. They've made a lot of progress, several products progressing thru clinical trials, significant milestone payments and licensing, major alliences, and their prices drop even on good news (look at VICL news last few weeks and inverse price response. Paula - do you hold other bio-techs that are kicking post..? Scott If the fundimentals realy are there the market will respond eventually. One of the biggest mistakes I ever made was selling AMAT Spring 96 at 38. Eventually the market found the value. My broker urged me to sell EQNX in August when it was at 11 & going nowhere. Hit 18 7/8th today. Glad I stuck to my evaluation this time. Big question for TRIBY longs is to honestly assess if the company is fundimentally strong. Then act on your research. FYI Scott